Speech-Language Pathologists in Whitestone, NY Accepting Medicare
221 Speech-Language Pathologists found. Showing 61 - 80
 Gisele Paling Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0071 |
Panagiota Peggy Aggelis, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 345 149th St, Whitestone, NY 11357 Phone: 917-301-7726 |
Aimee Liguori Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14606 23rd Ave, First Floor, Whitestone, NY 11357 Phone: 631-833-1810 |
Tiffany A Blake Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0071 Fax: 718-767-0086 |
Briana Cotugno Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0091 Fax: 718-767-0086 |
Evangelia Yerolemou Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0091 |
Caitlin M Burke Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12-10 150th St, Whitestone, NY 11357 Phone: 718-358-7430 |
Miss Sydney Surrago, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0091 |
Anita Pinto Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, C/o All In1 Spot, Whitestone, NY 11357 Phone: 718-767-0091 Fax: 718-767-0086 |
Mrs. Christine Asaro Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0091 |
Nardin Sargios Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0091 Fax: 718-767-0086 |
Nicole Oestricher Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0071 |
Alessia Vitale Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0071 |
Kristen Distefano, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0071 |
Alexa Caridi Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0071 |
Mrs. Sharmilla Indira Persaud Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0071 |
Lisa Diehm Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0071 |
Miss Sybil Doleyres Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0091 Fax: 718-767-0086 |
Kimberly Lin, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15050 14th Rd, Whitestone, NY 11357 Phone: 718-767-0071 |
Ashley Trovato Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1210 150th St, Whitestone, NY 11357 Phone: 718-728-8476 |
News Archive
Sunshine enters Adva-27a cancer research and development agreement with The Jewish General Hospital
Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Jewish General Hospital, one of McGill University's Hospital Centers, to conduct the necessary research and development to advance Sunshine's lead compound, Adva-27a, through the various stages of preclinical studies and Phase I clinical trials.
Lung-MAP, ALCHEMIST clinical trials offer innovative study designs for lung cancer patients
The recent launch of two clinical trials offer innovative study designs for patients with lung cancer. These clinical trials are the direct result of a National Cancer Institute sponsored workshop chaired by Drs. Fred R. Hirsch, Shakun Malik and Claudio Dansky- Ullman, that brought together the NCI Thoracic Malignancies Steering Committee, the US Food and Drug Administration, academicians, clinicians as well as industry and government stakeholders to discuss issues and challenges related to clinical trial design and biomarkers for lung cancer targeted-therapies.
GG genotype may increase severity of multiple sclerosis symptoms: Study
A new study shows a gene variant may increase the severity of multiple sclerosis (MS) symptoms. The research will be published in the August 3, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.For the study, researchers screened the oligoadenylate synthetase gene in 401 people with MS, 394 people without MS and 178 people receiving the MS treatment beta interferon.
FORMA Therapeutics closes Series B financing to a total of $25.5 million
FORMA Therapeutics today announced that it has closed on a Series B financing that raised a total of $25.5 million. The round was led by new investor Lilly Ventures, with participation from existing investors Novartis Option Fund and Bio*One Capital of Singapore.
New tool to identify children with severe sepsis reduces missed diagnoses by 76%
An electronic sepsis alert using a combination of vital signs, risk factors and physician judgment to identify children in a pediatric emergency department with severe sepsis reduced missed diagnoses by 76 percent.
› Verified 5 days ago
Speech-Language Pathologists
Physical Therapists
Occupational Therapists
Chiropractors
Optometrists
Podiatrists
Audiologists